Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10593825 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
Androgen receptor activity drives incurable castrate-resistant prostate cancer. All approved antiandrogens inhibit androgen receptor-driven transcription, and in addition the second-generation antiandrogen MDV3100 inhibits ligand-activated androgen receptor nuclear translocation, via an unknown mechanism. Here, we report methoxychalcones that lock the heat shock protein 90-androgen receptor complex in the cytoplasm in an androgen-non-responsive state, thus demonstrating a novel chemical scaffold for antiandrogen development and a unique mechanism of antiandrogen activity.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yeong Sang Kim, Vineet Kumar, Sunmin Lee, Aki Iwai, Len Neckers, Sanjay V. Malhotra, Jane B. Trepel,